Care PMS Growth Plus Value Strategy found it place among top performing strategy in 6 month and 1 year bracket in recent article published by economictimes.
Indian Economy
RBI in its December policy meeting upgraded India’s GDP forecast and expects economy to shrink 7.5% this fiscal vs earlier forecast of 9.5% contraction as the economy is recuperating faster than anticipated. Further, even the IMF upgraded its forecast for GDP growth in FY22 (8.8% growth earlier to 11.5% growth) making it the only key nation to record a double-digit growth and reclaim the status of world’s fastest growing major economy.
Additionally, RBI expects growth to be in positive trajectory for Oct-Dec 2020 period and predicts a V-shaped recovery in FY21 driven by rollout of vaccine. Also, since mid-September, India has done well to flatten the curve of Covid-19 cases. The number of active cases had fallen to 1.5 lakh from a peak of 10 lakh cases in September.
CARE PMS’s smallcap scheme Growth Plus Value (up 16.58 per cent), Unifi Capital’s Hold Co Fund (up 12.80 per cent) and Marcellus’ Rs 456 crore largecap scheme Consistent Compounders (up 11.40 per cent) emerged top performers of the month.
Emkay Investment Managers’ Emkay Lead PMS, Sundaram AMC’s SISOP, Sameeksha Capital’s Multicap equity fund, Marathon Trends’ Megatrends, Accuracap’s Dynamo delivered 10-11 per cent.
Click here to read full article on Economic Times
